Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreEvaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial
Type de publicationJournal Article
Year of Publication2015
AuteursAvet-Loiseau H, Corre J, Lauwers-Cances V, Chretien M-L, Robillard N, Leleu X, Hulin C, Gentil C, Arnulf B, Belhadj K, Brechignac S, Garderet L, Karlin L, Marit G, Benboubker L, Orsini-Piocelle F, Royer B, Drenou B, Tiab M, Lamy T, Macro M, Richardson PG, Anderson KC, Faham M, Facon T, Moreau P, Attal M, Munshi NC
JournalBLOOD
Volume126
Date PublishedDEC 3
Type of ArticleMeeting Abstract
ISSN0006-4971